Argentina
Industry
In a ruling that will have major implications for the country's healthcare system Argentina's senate has passed a law that recognises eating disorders, including obesity, anorexia...
2008-08-15Industry
Argentina's Ministry of Health has granted a major contract to state medicine producers in a bid to support local pharmaceutical production. A contract worth ARS37mn (US$12.2mn) has...
2008-08-07Industry
The Federation of Health Professionals of Argentina (Fesprosa) has called for an investigation by the country's pharmaceutical regulator ANMAT into an ongoing phase IIIb clinical...
2008-07-15Industry
With a view to consolidating its operations into key regions, US-based Valeant Pharmaceuticals has divested its Argentine operations to an unnamed local pharmaceutical company for...
2008-06-11Companies
In a move that demonstrates contrasting views of the importance of a local presence in emerging markets to innovative pharmaceutical companies, US-based Bristol-Myers Squibb (BMS)...
2008-06-11Industry
Argentina is to introduce new rules governing clinical trials from March, lending weight to BMI's view that the country's regulatory environment is on an upward trajectory. The rules...
2008-02-18Companies
Following positive steps by Argentina to improve its regulatory environment, BMI has upgraded the country's Business Environment Rating (BER) for the Approvals Process subcategory...
2007-12-14Industry
Two recent decisions by Argentina's medicines regulator ANMAT that mirror directives issued by the US FDA have served to demonstrate that it is watching the US regulator closely when...
2007-11-14
